ESPR earnings: a positive outcome, +7.7%

On August 2, 2022, Esperion Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.7% in the window around the event. It had already run -10.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.